in

Browse by Tags

  • Pharma still keen on M&As

    The Indian pharmaceutical sector is keeping the M&A fire burning with six deals concluded last month, up from eight in the January-March period. The list includes Jubilant Organosys' $255m acquisition of US-based DRAXIS Health and the $218m buyout of Dabur Pharma by Fresenius Kabi . Indian companies...
    Posted to ICIS Blogs (Weblog) by Anonymous on 05-15-2008
  • Testing times for CRAMS

    Business is booming in India’s custom research and manufacturing services (CRAMS) industry thanks to the country's strong process chemistry skills, low operational costs and the availability of a skilled workforce. Frost & Sullivan values the Indian CRAMS market at $890m, and expects it to expand...
    Posted to ICIS Blogs (Weblog) by Anonymous on 02-11-2008
Page 1 of 1 (2 items)
© RBI 2008
Powered by Community Server (Commercial Edition), by Telligent Systems